Efficacy and safety of biological and targeted-synthetic DMARDs: a systematic literature review informing the 2016 update of the ASAS/EULAR recommendations for the management of axial spondyloarthritis

OBJECTIVES: To update the evidence for the efficacy and safety of (b)biological and (ts)targeted-synthetic disease-modifying anti-rheumatic drugs (DMARDs) in patients with axial spondyloarthritis (axSpA) to inform the 2016 update of the Assessment of SpondyloArthritis international Society/European...

Descripción completa

Detalles Bibliográficos
Autores principales: Sepriano, Alexandre, Regel, Andrea, van der Heijde, Désirée, Braun, Jürgen, Baraliakos, Xenofon, Landewé, Robert, Van den Bosch, Filip, Falzon, Louise, Ramiro, Sofia
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BMJ Publishing Group 2017
Materias:
Spondyloarthritis
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278329/
https://www.ncbi.nlm.nih.gov/pubmed/28176964
http://dx.doi.org/10.1136/rmdopen-2016-000396

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5278329/
https://www.ncbi.nlm.nih.gov/pubmed/28176964
http://dx.doi.org/10.1136/rmdopen-2016-000396

Ejemplares similares